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Overview
Illegal pesticide application. In early April
1997, information provided by authorities in
Mississippi to the U.S. Environmental
Protection Agency (U.S. EPA) Region 5 led
to the discovery of an illegal methyl parathion
(MP) spraying operation in the Chicago,
Illinois, area. MP was used illegally to treat
for cockroaches in residences. Under federal
warrant, the U.S. EPA seized more than 200
gallons of MP concentrate, spraying equip-
ment, empty containers of MP, and business
records from the home of the illegal operator
on 9 April 1997. The records and receipts of
the illegal pest control operator (PCO) identi-
ﬁed hundreds of names, addresses, and phone
numbers of customers dating to the early
1990s. The addresses from the log books were
entered into a database and potentially conta-
minated homes were identified throughout
the west and south sides of Chicago and in
neighboring western suburbs. Many of these
addresses consisted of multiple households.
The PCO was arrested in April 1997 and
pleaded guilty to the charges of illegal pesti-
cide application in July 1997. He was subse-
quently sentenced in December 1997 to serve
2 years in prison.
Multiagency task force. In mid-April
1997 the federal Agency for Toxic
Substances and Disease Registry (ATSDR)
and the U.S. EPA organized an MP multia-
gency task force in Chicago to develop and
coordinate federal, state and local response
efforts. The task force included representa-
tives from the ATSDR, U.S. EPA, Illinois
Department of Public Health (IDPH),
Chicago Department of the Environment
(CDOE), Illinois Environmental Protection
Agency (IEPA), Illinois Department of
Agriculture, Cook County Department of
Public Health (CCDPH), Chicago
Department of Public Health (CDPH),
Illinois Cooperative Extension Service,
Illinois Poison Control Center, and Great
Lakes Center for Environmental and
Occupational Health. These agencies and
groups provided the staff and resources for
the Chicago area MP response.
The task force identified several primary
goals of the MP response: to characterize the
extent of MP contamination in homes, to
minimize or eliminate exposure to MP, to
identify affected individuals and provide
medical treatment if necessary, to educate
area residents and health care providers
about the health effects of exposure to MP,
and to provide residents and property own-
ers with alternative pest-management strate-
gies. The Chicago area MP response plan
was based primarily on the “Proposal for
para-Nitrophenol Monitoring in Urine to
Track Exposure to Methyl Parathion” devel-
oped by the Methyl Parathion Health
Sciences Steering Committee led by ATSDR
and U.S. EPA in April 1997 (1). This docu-
ment outlined environmental and biologic
levels of concern and sample criteria imple-
mented by the task force. An MP expert
panel also was convened by ATSDR to
review and comment on the steering com-
mittee report. The expert panel identified
data gaps that could affect the efﬁcacy of the
response, but the panel concurred with the
overall recommendations of the steering
committee (2).
Environmental sampling. Potentially
affected households were identified from
more than 40 receipt books conﬁscated from
the home of the applicator. Additional house-
holds were identified from an MP hotline
that was established at the beginning of the
response by the task force. The hotline num-
ber was printed and distributed in all fact
sheets developed for the response and it was
included in all communications with resi-
dents of potentially affected homes. Local
news media also printed and displayed the
hotline number over a period of several days
as the extent of contamination was being
investigated. All potentially treated homes
were eligible for environmental sampling to
characterize the extent of MP contamination.
Environmental sampling protocols were
developed by the U.S. EPA to provide uniform
sample information for affected homes (3). A
maximum of nine wipe samples were collected
from each residence on swabs charged with
isopropyl alcohol. Sample locations included
kitchen, living room, primary and secondary
bedroom baseboards, kitchen counter top
splash board, and under the kitchen sink.
Composite samples from high contact areas in
the living room and primary bedroom were
also collected in most homes. The sample col-
lection protocol included personal protection
speciﬁcations for sample team members.
Environmental sampling was scheduled by
CDPH and CCDPH. Environmental sam-
pling teams were led by the U.S. EPA and
IDPH, with trained personnel from several
participating agencies. These sampling teams
were assisted by the U.S. EPA, IEPA, and
CDOE community relations staff who distrib-
uted fact sheets and answered questions about
the process. Community relations staff also
administered a household questionnaire to
gather demographic and exposure information,
as well as health effect information.
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Information about the health of pets also was
obtained and was self-reported and unveriﬁed.
The household questionnaires were sent to
IDPH daily for review to prioritize sampling
of homes on the basis of any problematic
health conditions.
Environmental samples were collected,
documented, and sent to U.S. EPA or IDPH
laboratories for analysis. IDPH received envi-
ronmental sampling results and household
questionnaires and entered the information
into a department database. IDPH contacted
persons with health questions and provided
information or made referrals for medical
follow-up.
If the average level of MP in the household
environmental samples was <15 µg/100 cm2,
the household was cleared for no further action
(1). Clearance letters and educational materials
with information about proper methods of
pest control were sent to these households.
If MP was found at an average concen-
tration of ≥15 µg/100 cm2 in surface residue
samples in a household, urine sampling
was recommended for all residents in the
home (1).
Urine sampling. Residents who were
candidates for urine sampling were sent a
letter notifying them of their eligibility and
providing information about MP and urine
sampling procedures. CDPH and CCDPH
were then provided a list of households
eligible for urine sampling. Protocols for col-
lecting morning (A.M.) and evening (P.M.)
urine samples were developed by the
Methyl Parathion Health Science Steering
Committee (1) and collection forms and
questionnaires were developed by the task
force. Initially, local health department
nurses contacted eligible households to
schedule appointments for urine sampling.
IDPH and ATSDR trained the nurses to
handle samples properly, to administer ques-
tionnaires, and to answer questions. Nurses
traveled to the homes and met with residents
to explain the process and to provide sample
cups. The nurses returned to the household
the following day and collected the urine
sample cups and administered the urine
sample questionnaires. The samples were
transported to the IDPH laboratory in
Chicago for processing, freezing, and ship-
ment. The urine samples were then sent to
the Centers for Disease Control and
Prevention (CDC) laboratory in Atlanta,
Georgia, for analysis. Samples were tested
for para-nitrophenol (PNP), a metabolite of
MP. All questionnaires and paperwork were
sent to IDPH for data entry.
The use of local health nurses in Chicago
proved to be problematic. The collection of
urine samples for MP was a task added to an
already extensive work load. When funding
from ATSDR became available in the summer
of 1997, contract nurses were hired by
CDPH. These nurses were trained and
assigned the exclusive task of collecting urine
samples from residents within the Chicago
city limits. This revision in the response was
extremely effective and improved the urine
collection process in Chicago.
The CDC laboratory analyzed the urine
samples, adjusted the sample results for
creatinine (CR), and reported the results to
IDPH. The urine results and questionnaire
information were entered into the IDPH
database, and households were categorized
based on criteria in the “Proposal for para-
Nitrophenol Monitoring in Urine to Track
Exposure to Methyl Parathion” (Table 1) (1).
Households eligible for relocation were
referred to the U.S. EPA. IDPH sent letters
and information to households that required
quarterly urine sampling or no further action.
Methyl Parathion • McCann et al.
Table 1. Methyl parathion urine and environmental sampling criteria for household classification and
relocation.a,b
Recommended action No further action Urine monitoringc Relocation
Age group
<1 year and <25 ppb in urine; 25–50 ppb in urine; >50 ppb in urine
pregnant women <50 µg/100 cm2 or <25 ppb in urine
exposure-based sampling and ≥50 µg/100 cm2
exposure-based sampling
≥1 – <16 years <100 ppb in urine; 100–300 ppb in urine; >300 ppb in urine
<50 µg/100 cm2 or <100 ppb in urine
exposure-based sampling and ≥50 µg/100 cm2
exposure-based sampling
≥16 years <300 ppb in urine; 300–600 ppb in urine; >600 ppb in urine
<50 µg/100 cm2 or <300 ppb in urine
exposure-based sampling and ≥50 µg/100 cm2
exposure-based sampling
aAll exposure-based sampling is averaged. bAll urine numbers are CR adjusted; if CR numbers are not available, weight
basis is used. cThe initial urine sampling event will be based upon two discrete urine samples; the higher result will be
used for decisions. Frequency of urine monitoring will be once a quarter until the infant reaches 12 months of age. For all
other groups, monitoring will be conducted on a quarterly basis (regular intervals) for a minimum of 1 year to conﬁrm the
exposure scenario. Once the decision is made to collect urine samples in a house, all residents are to be offered monitor-
ing. Any individual from any category who exceeds established relocation benchmarks will trigger relocation. Data from
Methyl Parathion Health Sciences Steering Committee (1).
Table 2. Environmental sampling summary for methyl parathion in Chicago area homes.
Max Mean
Sample location (µg MP/100 cm2)( µg MP/100 cm2)
Kitchen baseboard composite (KBR), n = 895 9,750 242
Living room baseboard composite (LBR), n = 894 13,873 143
Bedroom 1 baseboard composite (BRB), n = 887 5,047 151
Bedroom 2 baseboard composite (BRX), n = 191 2,480 140
Average of KBR + LBR + BRB + BRX (BCA), n = 903 4,884 179
Composite of three high-contact areas (HCA), n = 896 994 10
Under kitchen sink (UKS), n = 886 12,000 217
Kitchen countertop/splash (KCS), n = 849 12,300 153
n, number of households sampled.
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Notification letters also were sent to
landlords of rental households. Residents
eligible for quarterly urine sampling were
contacted about 12 weeks after their previ-
ous sampling to schedule an appointment
for the next quarter sampling. This was done
for 1 year to ensure that MP exposure was
not increasing.
Relocation and remediation. The U.S.
EPA assembled a team to coordinate reloca-
tion activities. Team members included rep-
resentatives from the U.S. EPA, CDPH,
CCDPH, and IDPH. All remedial activities
were conducted by local hazardous waste
contractors with oversight by the U.S. EPA
on-scene coordinator.
A U.S. EPA community relations team
met with residents before relocation to
explain the procedure. Photographs were
taken and household items were inventoried
to document the status of the home prior to
remediation. Residents were moved to nearby
temporary housing and transportation was
provided for children so they could continue
to attend their neighborhood schools.
Contractors removed and replaced contami-
nated building materials and tested the home
to ensure clearance levels of <15 µg/100 cm2
were met before reoccupancy was allowed.
Health education. IDPH worked with
ATSDR Region 5 and the Great Lakes Center
for Environmental and Occupational Health
to provide community and health professional
education. IDPH also assisted ATSDR and its
contractor, Oak Ridge Institute for Science
and Education, in developing materials for
health professionals. A copy of a health profes-
sional fact sheet was sent electronically to
emergency department personnel throughout
the Chicago area. These education efforts
improved participation in the urine sampling.
Results
Scope of sampling and response. Through
applicator receipt books and the MP hotline,
968 homes were identified as having been
treated with MP. Of those homes, 903 were
environmentally sampled. Sampling was not
conducted in 65 homes because property
owners refused access or the property was
vacant. Of the 903 homes sampled, 307 had
MP levels <15 µg/100 cm2 and were cleared
from further investigation. MP levels
≥15 µg/100 cm2 were detected in 596 homes.
These homes were eligible to participate in
the urine monitoring phase of the response. A
summary of environmental sample results is
presented in Table 2.
Degradation of MP in the home was
evaluated with questionnaire information
regarding the last estimated spray date and
the baseboard contact average (BCA) that
was calculated from all baseboard samples in
the home (Figure 1). An estimated half-life
of about 300 days was calculated assuming
an exponential decay curve.
Initial urine samples were collected from
residents of 496 households. Individuals from
100 households refused to participate in the
urine monitoring. Urine samples were col-
lected from 1,913 individuals from these 496
households: 1,100 adults (≥16 years of age);
and 813 children, (<16 years of age). From
the initial urine sampling, 93 households
were recommended for relocation and reme-
diation, 261 households were recommended
to participate in quarterly monitoring, and
311 households were determined to require
no further action.
Participation in quarterly urine monitor-
ing gradually decreased. Of the 261 house-
holds recommended to participate in the
quarterly monitoring, residents from only
175 households submitted second-quarter
urine samples (Table 3). Third-quarter sam-
ples were collected from only 81 households,
and 66 households submitted fourth-quarter
samples (Table 3). On the basis of quarterly
monitoring, relocation and remediation were
recommended for nine households.
By the end of the MP response in
December 1998, 102 households were recom-
mended for relocation and remediation. This
included 550 residents: 232 adults (≥16 years
of age) and 318 children (<16 years of age).
Residents from two households refused to
relocate and allow remediation of their homes.
The majority of relocations were triggered
by children <6 years of age (Table 4). This
group also demonstrated the highest CR-
adjusted PNP (PNP/CR) levels (Table 5).
Health implications. Individuals from 225
homes reported illness after MP spraying.
Symptoms based on households included
headaches (67 households), nausea (41 house-
holds), flulike symptoms (27 households),
vomiting (23 households), dizziness (21
households), skin rash (9 households), and
respiratory effects (9 households). Medical
attention for these symptoms was reportedly
sought by residents of 96 households.
Residents from 128 households were able to
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Table 3. Quarterly urine monitoring summary for Chicago area homes with methyl parathion contamination.
No. of units No. of adults No. of children
Recommended for quarterly biomonitoring 261 588 345
No further action based on initial urine biomonitoring 311 626 498
Second-quarter urine samples  175 382 187
Second-quarter refusals/lost to follow-up 94 189 166
Third-quarter urine samples 81 165 83
Third-quarter refusals/lost to follow-up 79 174 81
Fourth-quarter urine samples 66 135 69
Fourth-quarter refusals/lost to follow-up 21 31 16
Table 4. Individuals in Chicago area homes triggering relocation based on morning and evening urine
samples.a
Persons triggering
Persons who relocation based on Persons triggering Persons triggering
submitted A.M. and/or either A.M. or P.M. relocation based on relocation based on
Age group P.M. urine samples urine sample A.M. urine sample P.M. urine sample
<1 year 29 19 (66%) 18 (90%) 16 (84%)
n = 20 n = 19
1–5 years 232 64 (28%) 56 (25%) 47 (23%)
n = 226 n = 208
6–16 years 549 48 (9%) 33 (6%) 33 (6%)
n = 538 n = 529
>16 years 1,100 7 (0.6%) 6 (0.6%) 4 (0.4%)
n = 1,078 n = 1,047
All 1,910 138 (7%) 113 (6%) 100 (5%)
n = 1,872 n = 1,809
Abbreviations: A.M., morning sample; n, number of samples submitted; P.M., evening sample. aAge information was avail-
able for all but three participants.
Table 5. Creatinine-adjusted p-nitrophenol summary for individuals in Chicago area homes qualifying for
relocation.
No. of A.M. PNP/CR A.M. PNP/CR P.M. PNP/CR P.M. PNP/CR Protocol for
Age group persons mean (ppb) max (ppb) mean (ppb) max (ppb) relocation (ppb)
<1 year 19 253 (n = 17) 1,000 306 (n = 15) 1,200 ≥ 50
1–5 years 100 406 (n = 96) 3,200 367 (n = 97) 3,415 ≥ 300
6–16 years 171 206 (n = 168) 1,700 189 (n = 169) 1,600 ≥ 300
>16 years 227 123 (n = 220) 1,800 116 (n = 216) 1,800 ≥ 600
n, number of samples.recall the time of onset of symptoms in rela-
tion to the MP application in their homes.
Onset of symptoms reportedly occurred
immediately after or the same day as the MP
application in 28 households. Other responses
indicated that symptom onset ranged from
2 days to 2 years after MP application. These
symptoms reportedly decreased over time.
Residents of 23 households reported
that pets either became ill or died after MP
application in their home. Six households
indicated a pet died shortly after MP appli-
cation. Residents from 11 households
sought veterinary care for their pets.
Discussion
Response challenges. The Chicago area MP
response posed many challenges for the mul-
tiagency MP task force. The initial challenge
of convening a multiagency task force and
defining roles and responsibilities required
many meetings and much dialogue between
agency representatives. Completion of the
“Proposal for para-Nitrophenol Monitoring
in Urine to Track Exposure to Methyl
Parathion” by the Methyl Parathion Health
Sciences Steering Committee provided a pro-
tocol for structuring the response and greatly
aided the effort to define individual agency
roles. Resources for participation in the
response were then determined and allocated
by each participating agency, and teams were
developed. The U.S. EPA and ATSDR pro-
vided leadership and direction necessary for
the successful operation of the task force.
Limited resources of participating agencies
posed a challenge during the 20-month
response. Resources normally used for other
programs were redirected to characterize the
MP contamination in homes and exposure of
residents. These resources included staff,
funds, laboratory support, and sampling
equipment. The multiagency approach to the
MP response helped to reduce the burden of
participating agencies and resulted in manage-
able resource allocation to complete the
response.
The high refusal rate for sampling of
households potentially contaminated with
MP was a difﬁcult problem for the task force.
The major concern was the potential expo-
sure of children who resided in households
where a parent or guardian refused access to
the sampling teams. Legal options that would
require property owners to allow access were
discussed and explored, but nothing enforce-
able was developed. Tracking rental units
where occupants had refused access was a task
force priority. The task force hoped to ﬁnd a
way to ensure that future occupants would be
informed that the property may have MP
contamination. The Chicago City Council
utilized an existing ordinance to require prop-
erty owners to provide written disclosure of
MP contamination and documentation of
any remedial work during real estate or rental
transactions (4). Disclosure of contamination
in Cook County homes outside the Chicago
city limits was more difficult. Disclosure of
MP contamination fell under the jurisdiction
of local city or village government authorities,
and no uniform response was developed or
enforced by county ofﬁcials.
The popularity of the illegal PCO
contributed to the number of access refusals.
Some residents, in refusing to allow sampling,
stated their concern for the welfare of the
PCO. The PCO had a good reputation in
some neighborhoods because customers
thought he provided a reliable, effective ser-
vice at a reasonable price. The conviction and
subsequent sentencing of the PCO may have
convinced some residents to reconsider their
refusal to grant access.
Conclusions
As a result of the Chicago area MP response,
exposure to MP was reduced and, in most
cases, eliminated. Based on self-reporting,
exposure to MP resulted in acute symptoms
shortly after spraying, but these symptoms
did not persist and decreased over time.
Long-term health implications of exposure to
MP are unknown.
The multiagency task force demonstrated
that cooperation between federal, state, and
local authorities is possible and can result in
an effective public health response. This
approach allowed participating agencies to
share and to more finely focus existing
resources. Of particular advantage was the
expertise and oversight provided by ATSDR
and the U.S. EPA. The lessons learned and
the working relationships developed during
the MP response have improved the ability of
federal, state, and local government agencies
to respond to environmental and public
health crises in Illinois.
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